Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 6, 2012, Pages 1472-1477

  Ellingson, Benjamin M ^a   Zaw, Taryar ^a   Cloughesy, Timothy F ^a   Naeini, Kourosh M ^a   Lalezari, Shadi ^a   Mong, Sandy ^a   Lai, Albert ^a   Nghiemphu, Phioanh L ^a   Pope, Whitney B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

brain tumor; CBV; cerebral blood volume; DSC; dynamic susceptibility contrast MRI; glioma; MRI

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; COEFFICIENT OF VARIANCE; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; DYNAMIC SUSCEPTIBILITY CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMAN; IMAGE ANALYSIS; IMAGE INTENSITY TRANSFORMATION GAUSSIAN NORMALIZATION; IMAGE INTENSITY TRANSFORMATION STANDARDIZATION; IMAGE INTENSITY TRANSFORMATION Z SCORE NORMALIZATION; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PRIORITY JOURNAL; WHITE MATTER;

AGED; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DATA INTERPRETATION, STATISTICAL; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862098770     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23600     Document Type: Article

References (19)

1. Rosen BR, Belliveau JW, Vevea MJ, Brady TJ,. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249-265. (Pubitemid 20248610)
2. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
3. Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging - prediction of patient clinical response. Radiology 2006; 238: 658-667. (Pubitemid 43134379)
4. Quarles CC, Ward BD, Schmainda KM,. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation. Magn Reson Med 2005; 53: 1307-1316. (Pubitemid 40734650)
5. Schmainda KM, Rand SD, Joseph AM, et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. AJNR Am J Neuroradiol 2004; 25: 1524-1532. (Pubitemid 44383603)
6. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993; 189: 233-238. (Pubitemid 23292954)
7. Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000; 6: 2189-2200. (Pubitemid 30399184)
8. Bedekar D, Jensen T, Schmainda KM,. Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons. Magn Reson Med 2010; 64: 907-913.
9. Nyul LG, Udupa JK, Zhang X,. New variants of a method of MRI scale standardization. IEEE Trans Med Imaging 2000; 19: 143-150. (Pubitemid 30594807)
10. Nyul LG, Udupa JK,. On standardizing the MR image intensity scale. Magn Reson Med 1999; 42: 1072-1081.
11. Hauk O, Wakeman DG, Henson R,. Comparison of noise-normalized minimum norm estimates for MEG analysis using multiple resolution metrics. Neuroimage 2011; 54: 1966-1974.
12. Bedekar DP, Jensen T, Paulson E, Schmainda KM,. Validation of a standardization technique for brain tumor rCBV maps and post-contrast anatomic images. In: Proc 16th Annual Meeting ISMRM, Toronto; 2008. p 3482.
13. Paulson ES, Schmainda KM,. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008; 249: 601-613.
14. Boxerman JL, Schmainda KM, Weisskoff RM,. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006; 27: 859-867. (Pubitemid 44897737)
15. Donahue KM, Krouwer HG, Rand SD, et al. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn Reson Med 2000; 43: 845-853. (Pubitemid 30387605)
16. Law M, Young R, Babb J, et al. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2006; 27: 1975-1982. (Pubitemid 44556520)
17. Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K,. Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging 1999; 17: 21-27. (Pubitemid 29036101)
18. Miyati T, Banno T, Mase M, et al. Dual dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 1997; 7: 230-235. (Pubitemid 28365666)
19. Vonken EP, van Osch MJ, Bakker CJ, Viergever MA,. Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000; 43: 820-827. (Pubitemid 30387602)